Comparative study of the bronchodilating effects of (-)- and (+)-oxyphenonium bromide.

Autor: Feitsma KG; Department of Analytical Chemistry and Toxicology, Groningen, The Netherlands., Postma DS, Koëter GH, Nossent GD, Brenth BF, de Zeeuw RA
Jazyk: angličtina
Zdroj: British journal of clinical pharmacology [Br J Clin Pharmacol] 1988 Jun; Vol. 25 (6), pp. 683-7.
DOI: 10.1111/j.1365-2125.1988.tb05253.x
Abstrakt: 1. Racemic oxyphenonium bromide, its enantiomers and placebo were inhaled by eight adult patients with chronic airflow obstruction, in a four-way double-blind cross-over study. 2. Forced expiratory volume in one second (FEV1) and slow inspiratory vital capacity (VC) were measured during the first 6 h after inhalation. 3. (+)-Oxyphenonium was found to be the active enantiomer (eutomer), providing better bronchodilation than (+/-)-oxyphenonium. 4. The distomer, (-)-oxyphenonium, showed only a slight effect on FEV1 and VC as compared with placebo.
Databáze: MEDLINE